Free Trial Information
BioCentury | Jul 11, 2016
Financial News

Cytune completes venture financing

Cytune Pharma S.A.S. , Nantes, France Business: Cancer Date completed: 2016-06-29 Type: Venture financing Raised: EUR6 million ($6.6 million) Investors: PPF Group; existing investors WIR Staff cancer...
Read More
BioCentury | Feb 16, 2015
Company News

Cytune cancer news

...acquired an undisclosed minority stake in Cytune. PPF also committed to funding R&D related to Cytune’s...
...IL-15 and IL-15 receptor alpha ( IL-15RA ), is in preclinical testing to treat cancer. Cytune Pharma S.A.S....
Read More
BioCentury | Apr 24, 2014
Distillery Therapeutics

Indication: Cancer

...a-chain (IL-15RA), in Phase I testing to treat melanoma and preclinical development for other cancers. Cytune Pharma S.A.S....
Read More
Items per page:
1 - 3 of 3
BioCentury | Jul 11, 2016
Financial News

Cytune completes venture financing

Cytune Pharma S.A.S. , Nantes, France Business: Cancer Date completed: 2016-06-29 Type: Venture financing Raised: EUR6 million ($6.6 million) Investors: PPF Group; existing investors WIR Staff cancer...
Read More
BioCentury | Feb 16, 2015
Company News

Cytune cancer news

...acquired an undisclosed minority stake in Cytune. PPF also committed to funding R&D related to Cytune’s...
...IL-15 and IL-15 receptor alpha ( IL-15RA ), is in preclinical testing to treat cancer. Cytune Pharma S.A.S....
Read More
BioCentury | Apr 24, 2014
Distillery Therapeutics

Indication: Cancer

...a-chain (IL-15RA), in Phase I testing to treat melanoma and preclinical development for other cancers. Cytune Pharma S.A.S....
Read More
Items per page:
1 - 3 of 3